Follow
Treg therapy
Regulatory T cells (Tregs) are a type of T cell responsible for maintaining homeostasis and self-tolerance by suppressing immune responses. In this role, Tregs inhibit T cells and cytokine production to prevent autoimmunity. Cellular therapies including Tregs are used to treat disorders resulting from excessive immune responses such as autoimmune diseases, transplant rejection, and graft-vs-host disease.
What's Popular in Treg therapy
-
JUN 13, 2023Cancer
Exosomes are extracellular vesicles ranging from 30 to 150 nm in diameter that are released from various types of cells, ...Sponsored By: Sino BiologicalMAR 03, 2023Immunology
In recent years, we have learned a lot about the crucial role gut microbes play in our health and well being. The extent ...Written By: Carmen LeitchOCT 18, 2022Immunology
Introduction The immune system plays a dual role in inflammation and cancer development. Immune system effector cells ra ...Sponsored By: Sino BiologicalOCT 28, 2021Cancer
A family of proteins, known as transcription factors, regulate the biological process of converting DNA into RNA. T ...Written By: Katie KokolusMAR 02, 2021Immunology
Tumors have sneaky strategies for establishing themselves within healthy tissues, flourishing in plain sight of circulat ...Written By: Tara Fernandes
JUN 13, 2023
Cancer
Exosomes are extracellular vesicles ranging from 30 to 150 nm in diameter that are released from various types of cells,
...
Sponsored By:
Sino Biological
MAR 03, 2023
Immunology
In recent years, we have learned a lot about the crucial role gut microbes play in our health and well being. The extent
...
Written By:
Carmen Leitch
OCT 18, 2022
Immunology
Introduction The immune system plays a dual role in inflammation and cancer development. Immune system effector cells ra
...
Sponsored By:
Sino Biological
OCT 28, 2021
Cancer
A family of proteins, known as transcription factors, regulate the biological process of converting DNA into RNA. T
...
Written By:
Katie Kokolus
MAR 02, 2021
Immunology
Tumors have sneaky strategies for establishing themselves within healthy tissues, flourishing in plain sight of circulat
...
Written By:
Tara Fernandes
JAN 13, 2021
Immunology
Tumors use ingenious approaches to stay just out of reach of immune cells on patrol and avoid detection. Indeed, cancer
...
Written By:
Tara Fernandes
OCT 12, 2020
Drug Discovery & Development
Cancer immunotherapies are becoming increasingly promising as a standard-of-care treatment. However, despite their promi
...
Written By:
Annie Lennon
OCT 01, 2020
Immunology
Much like electrical wires that are encased in plastic insulating sheaths, nerve cells also are also surrounded by a sim
...
Written By:
Tara Fernandes
JUN 09, 2020
Immunology
For patients with type 1 diabetes, hope is around the corner with a new experimental therapy that uses genetically modif
...
Written By:
Tara Fernandes
-
AUG 23, 2023 | 8:00 AM
Do you want to bring your CAR NK cell and Treg cell research into clinical applications? Watch this webinar and explore Miltenyi Biotec’s solutions to advance CAR NK cell and Treg-base...Speaker: Dr. Julia Hengst , Dr. Martha Elia Luevano Salinas , Dr. Alina SteinbachSponsored By: Miltenyi BiotecNOV 08, 2022 | 8:00 AM
Date: November 08, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST) While flow cytometry shines by its flexibility, it requires a high level of expertise in antibody panel development,...AUG 09, 2022 | 8:00 AM
Date: August 09, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Regulatory T cells (Tregs) are an important T cell subpopulation that maintains immunological homeostasis. Today, Treg-...DEC 09, 2021 | 8:00 AM
Date: December 9, 2021 Time: 8:00am (PDT), 11:00am (EDT) Engineering human regulatory T cells (Tregs) with a chimeric antigen receptor (CAR) targeting donorderived human leukocyte antigen (H...NOV 16, 2021 | 8:00 AM
Date: November 16, 2021 Time: 8:00am (PDT), 11:00am (EDT) The unique suppressive function of regulatory T cells (Treg cells) makes them an interesting target cell population to study. In rec...
AUG 23, 2023 | 8:00 AM
Do you want to bring your CAR NK cell and Treg cell research into clinical applications? Watch this webinar and explore Miltenyi Biotec’s solutions to advance CAR NK cell and Treg-base...
Speaker:
Dr. Julia Hengst
, Dr. Martha Elia Luevano Salinas
, Dr. Alina Steinbach
Sponsored By: Miltenyi Biotec
NOV 08, 2022 | 8:00 AM
Date: November 08, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST) While flow cytometry shines by its flexibility, it requires a high level of expertise in antibody panel development,...
AUG 09, 2022 | 8:00 AM
Date: August 09, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Regulatory T cells (Tregs) are an important T cell subpopulation that maintains immunological homeostasis. Today, Treg-...
DEC 09, 2021 | 8:00 AM
Date: December 9, 2021 Time: 8:00am (PDT), 11:00am (EDT) Engineering human regulatory T cells (Tregs) with a chimeric antigen receptor (CAR) targeting donorderived human leukocyte antigen (H...
NOV 16, 2021 | 8:00 AM
Date: November 16, 2021 Time: 8:00am (PDT), 11:00am (EDT) The unique suppressive function of regulatory T cells (Treg cells) makes them an interesting target cell population to study. In rec...
OCT 05, 2021 | 7:00 AM
Date: October 05, 2021 Time: 7:00am (PDT), 10:00am (EDT) After new users become familiar with flow cytometry instrumentation and learn how to set up the instrument and acquire data, the next...
AUG 26, 2021 | 7:00 AM
Date: August 26, 2021 Time: 7:00am (PDT), 10:00am (EDT) Pancreatic ductal adenocarcinoma (PDAC) is a fatal disease with rising incidence and a remarkable resistance to current therapies. In t...
JUN 02, 2021 | 10:30 AM
Learning Objectives: 1. Understand how the outcome of PD-1 blockade is a summation of increased Teffector activity and increased Treg suppressive activity 2. Explain how PD-1 blockade leads...
OCT 10, 2019 | 12:00 PM
Tumor mutational burden (TMB) is an emerging biomarker that correlates with response to immunotherapeutic agents, such as checkpoint inhibitors. Recent studies indicate that a high mutation l...
Speaker:
Ravindra Kolhe, MD, PhD
-
JUN 02, 2021 | 5:30 AM PDT
Labroots is pleased to announce the inauguration of the Immuno-Oncology Virtual Event Series taking place on June 2, 2021. Immuno-oncology is considered by some to be...JUL 29, 2020
Immuno-Oncology & Cancer Biology The rapid development of immuno-oncology therapies has transformed the cancer treatment landscape. Discovering safe, potent, and persistent immune cell p...OCT 09, 2019 | 6:00 AM PDT
Labroots and the Cancer Research and Oncology Planning Committee are pleased to announce the 7th Annual Event in the Cancer Research & Oncology Week Virtual Event Series!...SEP 05, 2017 | 8:00 AM PDT
An industry leader in delivering instrument systems, reagents, and services to life science researchers,Beckman Coulter Life Sciences helps enable new discoveries in biology-based research...SEP 30, 2015 | 6:00 AM PDT
Welcome to Labroots 3rd Annual Event in the Cancer Research & Oncology Week Virtual Event Series!...
JUN 02, 2021
| 5:30 AM PDT
Labroots is pleased to announce the inauguration of the Immuno-Oncology Virtual Event Series taking place on June 2, 2021. Immuno-oncology is considered by some to be...
JUL 29, 2020
Immuno-Oncology & Cancer Biology The rapid development of immuno-oncology therapies has transformed the cancer treatment landscape. Discovering safe, potent, and persistent immune cell p...
OCT 09, 2019
| 6:00 AM PDT
Labroots and the Cancer Research and Oncology Planning Committee are pleased to announce the 7th Annual Event in the Cancer Research & Oncology Week Virtual Event Series!...
SEP 05, 2017
| 8:00 AM PDT
An industry leader in delivering instrument systems, reagents, and services to life science researchers,Beckman Coulter Life Sciences helps enable new discoveries in biology-based research...
SEP 30, 2015
| 6:00 AM PDT
Welcome to Labroots 3rd Annual Event in the Cancer Research & Oncology Week Virtual Event Series!...